Pain management principles in the critically ill.
Brian L Erstad, Kathleen Puntillo, Hugh C Gilbert...
https://pubmed.ncbi.nlm.nih.gov/19349403Actively Recruiting
Led by Pontificia Universidad Catolica de Chile · Updated on 2025-06-08
80
Participants Needed
2
Research Sites
23 weeks
Total Duration
P
Pontificia Universidad Catolica de Chile
Lead Sponsor
A
Agencia Nacional de Investigación y Desarrollo
Collaborating Sponsor
Researchers are investigating a new multiparameter monitoring system called ROMANTIC to improve sedation management in critically ill patients in intensive care units (ICUs). Sedation dosing is crucial to avoid complications like delirium, prolonged ventilation, and increased mortality. Current sedation monitoring methods, such as clinical scales (RASS/SAS), have limitations especially when patients are unresponsive or using neuromuscular blockers. ROMANTIC aims to use machine learning with various patient data—including demographic, pharmacological, hemodynamic, respiratory, and EEG information—to better classify sedation status into underdosing, appropriate dosing, or overdosing categories. The study has two phases: first, a prospective observational cohort study collecting comprehensive data from ICU patients receiving sedation and mechanical ventilation for over 24 hours. Data include vital signs, sedation drugs (Fentanyl with Propofol or Midazolam), EEG signals, and clinical sedation scales recorded hourly. Two or three data collection windows occur per patient, starting after intubation, during sedation suspension, and if needed, during re-sedation. The second phase uses this data to develop and test a machine learning model that informs ICU staff about patients' sedation depth. Participants will be monitored through detailed clinical and laboratory assessments during their ICU stay, including sedation scales, EEG, hemodynamics, respiratory parameters, pain scores, neuromuscular blockade tests, and blood samples for drug concentrations. Delirium will be assessed twice daily after awakening. The primary outcome is time to extubation after sedation suspension, with secondary outcomes including length of ICU stay, duration of mechanical ventilation, incidence of ICU delirium, and serum sedative levels. The study's goal is to create a tool that helps non-specialized staff determine sedation levels more accurately and efficiently, potentially improving patient outcomes and ICU resource use.
CONDITIONS
multipaRameter mOnitoring systeM for sedAtion iNThe ICu
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 100 days during ICU hospitalization
Participants are observed while receiving sedation and mechanical ventilation in the ICU. Data including clinical, demographic, pharmacological, hemodynamic, ventilatory, EEG, pain, and neuromuscular blockade variables are collected during two or three data recording windows to assess sedation levels.
Continuous monitoring with data collection during 2 to 3 windows of approximately 6 hours each
Duration - Up to 5 days post-extubation
After sedation is suspended and participants awaken, delirium is assessed twice daily for up to 5 days post-extubation using the CAM-ICU tool by trained nursing staff.
Twice daily assessments (AM/PM) for up to 5 days
Total: 2 locations
1
Hospital Dr. Sotero del Rio
Santiago, Metropolitana de Santiago, Chile, 7700642
Not Yet Recruiting
2
Hospital Clínico Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile, 8330024
Actively Recruiting
J
Juan C. Pedemonte, M.D.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Brian L Erstad, Kathleen Puntillo, Hugh C Gilbert...
https://pubmed.ncbi.nlm.nih.gov/19349403Armando J Rotondi, Lakshmipathi Chelluri, Carl Sirio...
https://pubmed.ncbi.nlm.nih.gov/11940739Daniel L Jackson, Clare W Proudfoot, Kimberley F Cann...
https://pubmed.ncbi.nlm.nih.gov/20380720Michael C Reade, Simon Finfer
https://pubmed.ncbi.nlm.nih.gov/24476433John W Devlin, Yoanna Skrobik, Céline Gélinas...
https://pubmed.ncbi.nlm.nih.gov/30113379R R Riker, J T Picard, G L Fraser
https://pubmed.ncbi.nlm.nih.gov/10446827Curtis N Sessler, Mark S Gosnell, Mary Jo Grap...
https://pubmed.ncbi.nlm.nih.gov/12421743Felix Balzer, Björn Weiß, Oliver Kumpf...
https://pubmed.ncbi.nlm.nih.gov/25928417Yahya Shehabi, Rinaldo Bellomo, Michael C Reade...
https://pubmed.ncbi.nlm.nih.gov/22859526M H Kollef, N T Levy, T S Ahrens...
https://pubmed.ncbi.nlm.nih.gov/9726743